Titan Spine completes funding round: 3 things to know

Written by Mackenzie Garrity | November 07, 2018 | Print  |

Titan Spine closed a series B financing round, with current investment partner Southlake Equity Group leading the round.

Here are three things to know:

1. The surface technology company plans to use the funding to drive next stage growth, including new product lines, sales team expansion and accelerated research and development.

2. Since June 2016, Titan Spine has grown nearly 65 percent in the North American spine market. It has been able to add sales personnel, expand its third-party distributor network, launch a new distribution center and expand its products into new markets.

3. Southlake Equity Group led Titan Spine's series A financing round in June 2016.

"Titan Spine’s core business is to help patients that are suffering from back pain enjoy healthier, productive and pain-free lives as quickly as possible following surgery," said Titan Spine CEO Peter Ullrich, MD. "Our nanoLOCK proprietary surface technology was designed to do just that by fueling the patient’s own healing mechanisms at the nano-level."

More articles on surface technology:
Additive manufacturing company introduces new 3D-printed PEEK application — 3 things to know
FDA clears Zimmer Biomet's patient-specific revision knee system
New titanium interbody for spinal fusions earns FDA clearance: 4 things to know

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.